Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CID-25014542 is an inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 15 nM).1 It is selective for LRRK2 over a panel of 44 other kinases but does inhibit MAPK4 and Pim-2 at 1 µM. CID-25014542 (10 µM) also inhibits FMS-related tyrosine kinase 3 (FLT3). It decreases the production of amyloid-β (1-42) (Aβ42) in a reporter assay using H4 cells overexpressing Aβ42 (IC50 = 15 µM). CID-25014542 (20 µM) inhibits EGF-induced activation of MAPK in serum-starved cells.2 It increases the survival of primary rat granule neurons in low potassium media when used at concentrations of 1, 5, or 25 µM.3
WARNING This product is not for human or veterinary use.
1. Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond. Bioorg. Med. Chem. Lett. 24(19), 4630-4637 (2014).
2. A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity. Anticancer Drug Des. 16(1), 1-6 (2001).
3. Synthesis and structure-